Related Experiment Video
Updated: Aug 14, 2026

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
From Uptake to Therapeutic Function in Engineered Exosome Delivery Systems
Yiwei Li1, Limin Jin1, Pengli Gao1
1Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, PR China.
Engineered exosomes show promise for precision drug delivery. Evaluating their effectiveness requires assessing cargo, site of action, and therapeutic mechanism beyond just cellular uptake.
Area of Science:
- Biotechnology and Nanomedicine
- Drug Delivery Systems
Background:
- Engineered exosomes are emerging as advanced carriers for targeted drug delivery.
- Various engineering strategies (genetic, chemical, physical, hybrid) enhance exosome functionality but add complexity to outcome interpretation.
Purpose of the Study:
- To critically review engineered exosome delivery from cellular uptake to therapeutic outcomes.
- To analyze engineering strategies, targeting validation, endocytic pathways, intracellular fate, and functional readouts.
- To discuss the strengths and limitations of current evaluation methods for engineered exosomes.
Main Methods:
- Comprehensive literature review of engineered exosome applications in drug delivery.
- Analysis of studies detailing exosome engineering, targeting, cellular uptake, and therapeutic efficacy.
- Evaluation of common methodologies used to assess engineered exosome delivery and function.
Main Results:
- Tissue accumulation or cellular uptake alone are insufficient metrics for engineered exosome efficacy.
- Delivery effectiveness is highly dependent on cargo type, intended site of action, disease model, and therapeutic mechanism.
- Current evaluation methods have limitations that require careful consideration.
Conclusions:
- A holistic approach is needed to evaluate engineered exosome delivery, integrating engineering design, assay selection, and evidence strength.
- Interpreting engineered exosome delivery requires context-specific analysis for diverse biomedical applications.
- This review provides a framework for more rigorous assessment of engineered exosome-based therapeutics.
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Modified-Release Drug Delivery Systems: Site-Targeted
Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell eating"). Pinocytosis is...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
